Full-Time

Quality Compliance Senior Manager

Updated on 9/3/2026

Deadline 8/13/27
Eugia US

Eugia US

Sterile injectable medicines manufacturer

Compensation Overview

$154k - $174.8k/yr

No H1B Sponsorship

East Windsor, NJ, USA

In Person

Must reside within commuting distance of the East Windsor office; relocation benefits are not provided.

Bachelor's

Category
Biology & Biotech (1)
Required Skills
FDA Regulations
Requirements
  • Strong understanding of FDA regulations, GxP requirements, quality systems, compliance programs, and inspection readiness activities.
  • Working knowledge of current Good Manufacturing Practice requirements and their application within a pharmaceutical environment.
  • Experience managing quality systems, deviations, investigations, corrective and preventive actions, audits, and change controls.
  • Experience overseeing outsourced Pharmacovigilance programs, including vendor governance, quality oversight, performance monitoring, audit management, and compliance activities.
  • Experience managing vendor compliance programs, audits, and quality agreements.
  • Familiarity with Safety Data Exchange Agreements and third-party compliance oversight.
  • Familiarity with Drug Supply Chain Security Act requirements and pharmaceutical supply chain compliance.
  • Strong inspection readiness and audit management experience.
  • Ability to identify compliance risks and implement effective mitigation strategies.
  • Demonstrated leadership and people management experience, including coaching, development, and performance management.
  • Bachelor’s degree in Pharmacy, Life Sciences, Chemistry, Biology, or a related scientific discipline.
  • Minimum of 10 years of relevant experience with demonstrated leadership responsibility within Quality Compliance, Quality Systems, or GxP compliance programs.
  • Experience supporting FDA inspections and regulatory audits.
  • Experience within a commercial pharmaceutical organization.
  • Experience supporting products manufactured by global or third-party manufacturing partners.
  • Previous experience in Quality Compliance, Internal Audit, Pharmacovigilance Quality, or Vendor Quality Management functions.
  • Proven experience managing employees and developing high-performing teams.
  • Demonstrated success leading cross-functional compliance initiatives and organizational improvement efforts.
  • Demonstrated experience overseeing outsourced Pharmacovigilance vendors, quality systems, audits, compliance metrics, and vendor governance programs.
Responsibilities
  • Lead and continuously improve Quality Systems to ensure compliance with FDA regulations, GxP requirements, company procedures, and industry best practices.
  • Manage and maintain quality documentation, including standard operating procedures, policies, procedures, controlled documents, and records.
  • Oversee deviations, investigations, corrective and preventive actions, change controls, and associated effectiveness monitoring activities where applicable.
  • Monitor and trend quality metrics, compliance performance indicators, and audit findings to identify risks and opportunities for continuous improvement.
  • Drive quality and compliance initiatives that strengthen operational effectiveness and inspection readiness.
  • Provide Quality oversight of outsourced Pharmacovigilance activities to ensure compliance with regulatory requirements, contractual obligations, and internal procedures.
  • Monitor Pharmacovigilance quality metrics, compliance trends, deviations, investigations, corrective and preventive actions, and vendor performance where applicable.
  • Support qualification, auditing, and ongoing oversight of Pharmacovigilance service providers and other GxP vendors.
  • Ensure Safety Data Exchange Agreements, quality agreements, and Pharmacovigilance-related quality documentation are maintained and compliant.
  • Partner with Pharmacovigilance, Regulatory Affairs, and external vendors to address compliance risks and drive continuous improvement.
  • Maintain inspection readiness for Pharmacovigilance-related activities and represent Quality during Pharmacovigilance audits, inspections, and regulatory inquiries.
  • Support Drug Supply Chain Security Act compliance programs and supply chain security initiatives.
  • Monitor evolving Drug Supply Chain Security Act requirements and support implementation of processes necessary to maintain compliance.
  • Partner with Supply Chain, Distribution, and external partners to ensure compliance with applicable tracing, serialization, and regulatory requirements.
  • Manage quality agreements, technical agreements, Safety Data Exchange Agreements, and other compliance-related agreements.
  • Lead qualification, risk assessment, periodic review, and ongoing oversight of GxP vendors, contract service providers, and business partners.
  • Coordinate vendor audits and ensure timely remediation and closure of audit findings and corrective and preventive actions.
  • Monitor vendor performance metrics and ensure compliance with contractual, regulatory, and quality requirements.
  • Manage the GxP training compliance program and ensure personnel maintain required training and qualifications.
  • Monitor training effectiveness and ensure training records are maintained in accordance with company procedures.
  • Promote awareness of quality and compliance expectations throughout the organization.
  • Develop and execute internal audit programs covering Quality Systems, Pharmacovigilance oversight, Drug Supply Chain Security Act activities, and outsourced GxP processes.
  • Conduct compliance assessments, identify risks and gaps, and drive remediation activities.
  • Coordinate inspection readiness activities and support mock inspection programs.
  • Serve as a key Quality representative during FDA inspections, customer audits, and regulatory interactions.
  • Ensure audit observations and inspection findings are effectively addressed through appropriate corrective and preventive action plans.
  • Provide day-to-day leadership, coaching, and development for Quality Compliance personnel.
  • Establish departmental goals, priorities, and performance expectations aligned with organizational objectives.
  • Foster a culture of quality, accountability, continuous improvement, and inspection readiness.
  • Support employee development, succession planning, and talent growth within the Quality organization.
  • Partner cross-functionally to ensure alignment of compliance initiatives and business objectives.
Desired Qualifications
  • Advanced degree.
  • Certified Quality Auditor or other relevant quality/compliance certification.

Eugia US is a pharmaceutical company focused on generic sterile injectable medicines. Scientific, engineering, production, quality, regulatory, supply-chain, and commercial teams support the product lifecycle. It develops, manufactures, markets, and distributes institutional products used by hospitals and pharmacies. The profile is Eugia's United States operation and its institutional medicines business. Roles include formulation, manufacturing, laboratory work, validation, maintenance, quality, regulatory affairs, sales, and operations. Its workforce connects frontline delivery with the specialist, operational, technical, and business teams that support the organization.

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

New Jersey

Founded

2011

Simplify Jobs

Simplify's Take

What believers are saying

  • Pomalidomide launched March 4, 2026, expanding Eugia's U.S. oncology lineup.
  • Everolimus approval positions Unit-I for Q1 FY27 commercialization and fresh revenue.
  • Unit-I received only four FDA observations in March 2026, showing stronger compliance.

What critics are saying

  • FDA classified Eugia Unit-III OAI on June 12, 2026 after 11 findings.
  • OAI blocks pending approvals from Unit-III and delays 2026-27 injectable launches.
  • An import alert on Unit-III would cripple U.S. sterile revenue and destroy credibility.

What makes Eugia US unique

  • Eugia Pharma Specialities led Aurobindo's 184th ANDA approval on February 26, 2026.
  • Unit-I launched Pomalidomide capsules in March 2026, entering U.S. oncology generics.
  • Eugia Unit-I won Everolimus tablet approval, targeting a $78 million market.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

401(k) Company Match

Paid Vacation

Paid Holidays